Development of a Prediction Model to Identify the Risk of Clostridioides difficile Infection in Hospitalized Patients Receiving at Least One Dose of Antibiotics.

IF 2 Q3 PHARMACOLOGY & PHARMACY
Pharmacy Pub Date : 2024-02-19 DOI:10.3390/pharmacy12010037
Abdulrahman Alamri, AlHanoof Bin Abbas, Ekram Al Hassan, Yasser Almogbel
{"title":"Development of a Prediction Model to Identify the Risk of <i>Clostridioides difficile</i> Infection in Hospitalized Patients Receiving at Least One Dose of Antibiotics.","authors":"Abdulrahman Alamri, AlHanoof Bin Abbas, Ekram Al Hassan, Yasser Almogbel","doi":"10.3390/pharmacy12010037","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study's objective was to develop a risk-prediction model to identify hospitalized patients at risk of Clostridioides difficile infection (CDI) who had received at least one dose of systemic antibiotics in a large tertiary hospital.</p><p><strong>Patients and methods: </strong>This was a retrospective case-control study that included patients hospitalized for more than 2 days who received antibiotic therapy during hospitalization. The study included two groups: patients diagnosed with hospital CDI and controls without hospital CDI. Cases were matched 1:3 with assigned controls by age and sex. Descriptive statistics were used to identify the study population by comparing cases with controls. Continuous variables were stated as the means and standard deviations. A multivariate analysis was built to identify the significantly associated covariates between cases and controls for CDI.</p><p><strong>Results: </strong>A total of 364 patients were included and distributed between the two groups. The control group included 273 patients, and the case group included 91 patients. The risk factors for CDI were investigated, with only significant risks identified and included in the risk assessment model: age older than 70 years (<i>p</i> = 0.034), chronic kidney disease (<i>p</i> = 0.043), solid organ transplantation (<i>p</i> = 0.021), and lymphoma or leukemia (<i>p</i> = 0.019). A risk score of ≥2 showed the best sensitivity, specificity, and accuracy of 78.02%, 45.42%, and 78.02, respectively, with an area under the curve of 0.6172.</p><p><strong>Conclusion: </strong>We identified four associated risk factors in the risk-prediction model. The tool showed good discrimination that might help predict, identify, and evaluate hospitalized patients at risk of developing CDI.</p>","PeriodicalId":30544,"journal":{"name":"Pharmacy","volume":"12 1","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2024-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10892393/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/pharmacy12010037","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: This study's objective was to develop a risk-prediction model to identify hospitalized patients at risk of Clostridioides difficile infection (CDI) who had received at least one dose of systemic antibiotics in a large tertiary hospital.

Patients and methods: This was a retrospective case-control study that included patients hospitalized for more than 2 days who received antibiotic therapy during hospitalization. The study included two groups: patients diagnosed with hospital CDI and controls without hospital CDI. Cases were matched 1:3 with assigned controls by age and sex. Descriptive statistics were used to identify the study population by comparing cases with controls. Continuous variables were stated as the means and standard deviations. A multivariate analysis was built to identify the significantly associated covariates between cases and controls for CDI.

Results: A total of 364 patients were included and distributed between the two groups. The control group included 273 patients, and the case group included 91 patients. The risk factors for CDI were investigated, with only significant risks identified and included in the risk assessment model: age older than 70 years (p = 0.034), chronic kidney disease (p = 0.043), solid organ transplantation (p = 0.021), and lymphoma or leukemia (p = 0.019). A risk score of ≥2 showed the best sensitivity, specificity, and accuracy of 78.02%, 45.42%, and 78.02, respectively, with an area under the curve of 0.6172.

Conclusion: We identified four associated risk factors in the risk-prediction model. The tool showed good discrimination that might help predict, identify, and evaluate hospitalized patients at risk of developing CDI.

开发一种预测模型,以确定至少接受过一次抗生素治疗的住院患者感染艰难梭菌的风险。
研究目的本研究的目的是建立一个风险预测模型,以确定在一家大型三级医院中至少接受过一次全身抗生素治疗的艰难梭菌感染(CDI)住院患者的风险:这是一项回顾性病例对照研究,研究对象包括住院超过 2 天且在住院期间接受过抗生素治疗的患者。研究包括两组:确诊患有医院 CDI 的患者和未患有医院 CDI 的对照组。病例与对照组按年龄和性别以 1:3 配对。通过比较病例和对照组,使用描述性统计来确定研究人群。连续变量以平均值和标准差表示。通过多变量分析,确定病例和对照组之间与 CDI 明显相关的协变量:两组共纳入 364 名患者。对照组包括 273 名患者,病例组包括 91 名患者。对CDI的风险因素进行了调查,仅发现了以下重要风险因素并将其纳入风险评估模型:年龄大于70岁(p = 0.034)、慢性肾病(p = 0.043)、实体器官移植(p = 0.021)、淋巴瘤或白血病(p = 0.019)。风险评分≥2的敏感性、特异性和准确性最好,分别为78.02%、45.42%和78.02,曲线下面积为0.6172:我们在风险预测模型中确定了四个相关风险因素。结论:我们在风险预测模型中确定了四个相关的风险因素,该工具显示出良好的辨别能力,可帮助预测、识别和评估有患 CDI 风险的住院患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pharmacy
Pharmacy PHARMACOLOGY & PHARMACY-
自引率
9.10%
发文量
141
审稿时长
11 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信